Elaj Remedies (India) Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 39 Year, 3 Months
- Last Filing with ROC 31 Mar 2011
- Open Charges ₹ 1.20 Cr
About Elaj Remedies (India)
Elaj Remedies (India) Pvt Ltd (ERIPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 October 1985 and has a history of 39 years and three months. Its registered office is in Aurangabad, Maharashtra.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2011. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.20 Cr.
Shweta Kanhere and Vijeta Korade serve as directors at the Company.
Company Details
-
LocationAurangabad, Maharashtra
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230MH1985PTC037718
-
Company No.
037718
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Oct 1985
-
Date of AGM
30 Sep 2011
-
Date of Balance Sheet
31 Mar 2011
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Elaj Remedies (India)?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shweta Kanhere
|
Director | 13-Apr-2012 | Current |
|
Vijeta Korade
|
Director | 23-Jul-2004 | Current |
Financial Performance of Elaj Remedies (India).
Enhance accessibility to Elaj Remedies (India)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Elaj Remedies (India)?
Unlock access to Elaj Remedies (India)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Edrok Formulation Private LimitedVijeta Korade is a mutual person
Charges (Loans)
₹12.00 M
₹0
Charges Breakdown by Lending Institutions
- Deogiri Nagari Sahakari Bank Limited : 0.85 Cr
- Deogiri Sahakari Bank Ltd : 0.35 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Oct 2012 | Deogiri Nagari Sahakari Bank Limited | ₹8.50 M | Open |
| 28 Sep 2004 | Deogiri Sahakari Bank Ltd | ₹3.00 M | Open |
| 22 Sep 2004 | Deogiri Sahakari Bank Ltd | ₹0.50 M | Open |
How Many Employees Work at Elaj Remedies (India)?
Unlock and access historical data on people associated with Elaj Remedies (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Elaj Remedies (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Elaj Remedies (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
